| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.0M | +220.7% |
| Cost of Revenue | $5.0M | +329.1% |
| Gross Profit | $8.0M | +177.1% |
| R&D Expense | $1.1M | -11.6% |
| SG&A Expense | $11.7M | -14.8% |
| Operating Income | -$14.1M | +43.9% |
| Interest Expense | $6.9M | +239.9% |
| Income Tax | $28K | — |
| Net Income | -$27.3M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $619K | -74.6% |
| Accounts Receivable | $2.4M | +2.5% |
| Inventory | $1.0M | -64.8% |
| Current Assets | $4.4M | -44.5% |
| Total Assets | $18.6M | -19.1% |
| Current Liabilities | $56.3M | +55.5% |
| Long-term Debt | $26.3M | +56.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | +49.6% |
| Capital Expenditures | $529K | +900.6% |
| Investing Cash Flow | -$529K | +97.4% |
| Financing Cash Flow | $5.1M | -84.7% |
| Free Cash Flow | -$6.9M | +45.7% |
| +11.9% |
| EPS (Basic) | -$0.05 | +37.5% |
| EPS (Diluted) | -$0.05 | +37.5% |
| Total Liabilities |
| $57.6M |
| +56.7% |
| Stockholders' Equity | -$39.0M | -184.0% |